Dr. Noa Simchoni, MD, PhD

Dr. Simchoni practices at Zuckerberg San Francisco General Hospital and Trauma Center in San Francisco, California, part of City and County of San Francisco, CA.

Dr. Simchoni's NPI, 1881127868, was assigned on April 6, 2017. Dr. Simchoni graduated from Icahn School Of Medicine At Mount Sinai in 2017. Dr. Simchoni holds California license A160238.

Dr. Simchoni's primary practice is Zuckerberg San Francisco General Hospital and Trauma Center, at 1001 Potrero Avenue, San Francisco, CA 94110 in San Francisco County. The practice phone is (415) 206-8000.

Dr. Simchoni's primary practice is Zuckerberg San Francisco General Hospital and Trauma Center in San Francisco, California, part of City and County of San Francisco, CA. Dr. Simchoni is also affiliated with UCSF Helen Diller Medical Center at Parnassus Heights. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Simchoni to 4 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Simchoni practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Simchoni's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Simchoni is board certified in critical care medicine by the American Board of Internal Medicine. Dr. Simchoni is licensed in California.

CMS data shows 18 Medicare services from Dr. Simchoni across 1 procedure code in 2021. Medicare paid $3,222 for them. Every service was in a facility, such as a hospital, rather than an office.

Across all payers, Dmand AI patient panel data puts Dr. Simchoni's median patient age at 74, with 56% women.

In 2024, Dr. Simchoni wrote 270 Medicare Part D claims for 40 patients. 39% of them were for generic drugs. CMS names the drug for 168 of them, across 8 drugs with 11 or more claims each, at $315,735 in total drug cost. In 2023, CMS named 114 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Simchoni for performance year 2024, reported as part of a group. Dr. Simchoni accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Simchoni as offering telehealth.

Dmand AI links 12 papers to Dr. Simchoni, published from 2014 to 2025. 2015 was the busiest year, with 7. The most frequent topics are B-Lymphocytes, High-Throughput Nucleotide Sequencing and Myeloid Differentiation Factor 88. Dr. Simchoni has published most often in Clin Immunol. Dr. Simchoni's most frequent co-authors are Anthony Shum, MD, Manish Ramesh, MBBS, PhD and Tiphanie Phillips Vogel, MD.

CMS Open Payments shows 1 general payment to Dr. Simchoni from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $110.

Dr. Simchoni graduated from Icahn School Of Medicine At Mount Sinai in 2017.

Dr. Simchoni is in network with 6 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.